Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Forecasted Growth Rate and Market Size of the Follicular Lymphoma Treatment Market?

In recent times, the market for follicular lymphoma treatment has witnessed robust growth. The market that stood at $3.05 billion in 2024 is projected to reach $3.28 billion in 2025, marking a compound annual growth rate (CAGR) of 7.5%. Factors contributing to the growth during the historic period include a rise in follicular lymphoma cases, advancements in cancer diagnosis, growth in the elderly population, development in clinical research and pharmaceuticals, and partnerships in the field of oncology research.

Expectations indicate strong growth in the follicular lymphoma treatment market size in the coming years. It is forecasted to reach a value of $4.49 billion by 2029, growing at a compound annual growth rate (CAGR) of 8.1%. Factors that could drive growth during the forecast period include advancements in personalized medicine and immunotherapy, wider availability of innovative therapies, focus on quality of life, and international collaborations in oncology. Notable trends for the forecast period encompass clinical trials, research initiatives, the exploration of epigenetic modifiers, improvements in radioimmunotherapy, the use of artificial intelligence (AI), and global cooperation to increase therapy access.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10758&type=smp

Which Factor Is Shaping The Future Of The Follicular Lymphoma Treatment Market?

The follicular lymphoma treatment market’s expansion is anticipated to be fueled by the escalating occurrence of follicular lymphoma. The term prevalence regarding follicular lymphoma refers to the overall count or ratio of people diagnosed with follicular lymphoma within a certain group during a specific period or over a certain duration. The reason behind this trend includes an increase in the aged population, genetic tendencies, advancements in diagnostic methods, and heightened awareness and screening. Treating follicular lymphoma aids in reducing its prevalence by targeting the disease in various stages, helping in the treatment and progress of the disease. The follicular lymphoma treatment market is experiencing growth due to increased follicular lymphoma incidents. For instance, as per the American Cancer Society in January 2023, non-Hodgkin lymphoma, an indolent form of follicular lymphoma, was the most common cancer in the US, comprising nearly 4% of all cancers. The American Cancer Society estimates that about 80,550 individuals (including 44,880 men and 35,670 women) will be diagnosed with non-Hodgkin lymphoma, encompassing both adults and children. Consequently, the surge in follicular lymphoma incidence is propelling the follicular lymphoma treatment market’s growth.

What Is The Segment-Wise Breakdown Of The Follicular Lymphoma Treatment Market?

The follicular lymphoma treatment market covered in this report is segmented –

1) By Treatment: Monoclonal Antibodies, Targeted Therapy, Chemotherapy, Radiation Therapy, Stem Cell Transplant, Alkylating Agents, Nucleoside Analogues, Anthracycline Derivatives, Other Treatments

2) By Product Type: Tablets, Capsules, Injectables, Other Product Types

3) By Route of Administration: Oral, Parenteral, Other Route of Administration

4) By End Use: Hospitals, Oncology Centers, Ambulatory Care Centers, Academic Research Institutes, Other End Users

Subsegments:

1) By Monoclonal Antibodies: Rituximab, Obinutuzumab, Ofatumumab

2) By Targeted Therapy: PI3K Inhibitors, BTK Inhibitors, BCL-2 Inhibitors

3) By Chemotherapy: CHOP Regimen, Bendamustine, Fludarabine

4) By Radiation Therapy: External Beam Radiation Therapy (EBRT), Radioimmunotherapy

5) By Stem Cell Transplant: Autologous Stem Cell Transplant, Allogeneic Stem Cell Transplant

6) By Alkylating Agents: Cyclophosphamide, Ifosfamide

Which Trends Are Redefining The Future Landscape Of The Follicular Lymphoma Treatment Industry?

Advancements in technology relating to the diagnosis and treatment of follicular lymphoma are creating significant opportunities within the market. Companies active in this sector are leveraging advanced diagnostic tools and treatment options to maintain their market standing. For example, in December 2022, the US biotechnology firm Genentech Inc. was granted FDA approval for Lunsumio, an innovative bispecific antibody developed for the treatment of refractory or relapsed follicular lymphoma. This antibody represents a new strain of fixed-duration cancer treatment immunotherapy which is ready to use and does not require patients to wait. This FDA approval stems from encouraging outcomes from Phase II GO29781 research trials of Lunsumio with extensively pretreated FL patients, particularly those with a high likelihood of disease progression or prior treatment non-responsiveness.

Which Companies Hold The Largest Market Share In The Follicular Lymphoma Treatment Sector?

Major companies operating in the follicular lymphoma treatment market include AbbVie Inc., Bayer AG, Bristol Myers Squibb Company, F. Hoffmann-La Roche Ltd., Johnson and Johnson Services Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co. Inc., EpiZyme Inc., Boehringer Ingelheim GmbH, CTI BioPharma Corp., Spectrum Pharmaceuticals Inc., Seattle Genetics Inc., Applied Molecular Genetics Inc., Daiichi Sankyo Company Ltd., Pfizer Inc., Incyte Corporation, MorphoSys AG, Regeneron Pharmaceuticals Inc., Eli Lilly and Company, Seagen Inc., Takeda Pharmaceutical Company, Nordic Nanovector ASA, ADC Therapeutics SA, MEI Pharma Inc., BeiGene Inc., TG Therapeutics Inc., Amgen Inc., Dr. Reddy’s Laboratories Ltd.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/follicular-lymphoma-treatment-global-market-report

How Does Regional Performance Compare Across The Follicular Lymphoma Treatment Industry?

North America was the largest region in the follicular lymphoma treatment market in 2024. The regions covered in the follicular lymphoma treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10758&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model